Experimental Immunology Branch, National Cancer Institute


Pierre Henkart laboratory

Administrative location:
Lymphocyte Cytototoxicity Section,
Experimental Immunology Branch,
Division of Basic Sciences,
National Cancer Institute,
National Institutes of Health

Mailing Address: Bldg.10, Room 4B17, NIH, Bethesda, MD 20892-1360

Telephone: 301-496-1554; Fax: 301-496-0887


Laboratory Personnel (email address)

Standing, from left:
Ming-Lei Wu, Ph.D. (mw129m@nih.gov)
Kirsi Allison, M.D. (ka39q@nih.gov)
Michelle Conan-Cibotti, Ph.D.(mc185o@nih.gov)
Seated, from left:
Mark S. Williams, Ph.D. (mw97y@nih.gov)
Apurva Sarin, Ph.D. (as39z@nih.gov)
Christina Spiezio, M.S. (cs146a@nih.gov)
Pierre A.Henkart, Ph.D. (ph8j@nih.gov)


Research Interests:
Molecular mechanisms of lymphocyte-mediated cytotoxicity
Molecular mechanisms of T lymphocyte apoptosis

Cytotoxic lymphocytes have been shown to be a potent immunological mechanism for the highly specific destruction of virus-infected and foreign cells, and most current immunological approaches to cancer therapy envision stimulating the differentiation of cytotoxic T lymphocytes with the ability to selectively recognize tumor cells. We have been studying the basic mechanism by which cytotoxic lymphocytes kill their target cells in vitro, and have developed the now well accepted granule exocytosis model for the lethal mechanism. The model proposes that cytotoxic lymphocytes rapidly secrete preformed mediators in response to target binding, utilizing a modified form of the regulated secretory process found in many cell types. However, the details of how proteins secreted by the killer lymphocyte cause target cell death remain to be elucidated. While we initially focussed on the pore-forming properties of the lymphocyte cytolysin/perforin molecule, we have recently found that the secreted serine proteases known as granzymes enter the target cell cytoplasm where they activate a resident apoptotic death pathway. We studied the properties of model cytotoxic lymphocytes created by transfecting the rat mast cell tumor RBL to express components of cytotoxic lymphocyte granules. A combination of cytolysin/perforin, granzyme A and granzyme B endowed these originally non-cytotoxic cells with a cytotoxic activity close to cloned cytotoxic T lymphocytes, including apoptotic target cell damage. Cytotoxic activity required cytolysin expression, and showed a synergism between granzymes A and B expression. Using enucleated target cells, we further showed that the nucleus is not required for the apoptotic target cell death due to secreted granzymes.

We have also been defining the molecular events of apoptotic death in T lymphocytes, particularly the role of two different types of cytoplasmic cysteine proteases. In the Fas-mediated death pathway triggered by T cell receptor crosslinking in T cell blasts, the TcR triggers the upregulation of Fas Ligand, which in turn crosslinks Fas. We have shown the calcium-dependent protease calpain is required for upregulation of Fas Ligand mRNA, based on selective blocking by calpain inhibitors including the highly specific protein calpastatin (expressed by transfection). We have also demonstrated a novel Fas-independent route of antigen-triggered T cell death by showing that T blasts are killed by TNF and lymphotoxin, cytokines secreted by activated T cells.

Developmental cell death in the nematode C. elegans requires the death gene ced-3, which codes for an intracellular cysteine protease cleaving proteins at aspartic acid. This protease is structurally and functionally related to the mammalian interleukin-1Beta; converting enzyme (ICE) and several other recently described human proteases. There is increasing evidence for a functional role for such ICE-like proteases in apoptotic death of mammalian cells. We are currently assessing their role in T lymphocyte programmed cell death and their involvement in death triggered by cytotoxic lymphocyes.

Recent publications

  1. Henkart PA, Williams MS, Nakajima H. Degranulating cytotoxic lymphocytes inflict multiple damage pathways on target cells: A cytolysin/perforin-mediated membrane damage pathway and a granzyme-mediated internal disintegration pathway. Curr.Top.Microbiol.and Immunol. 1995 198:75-93.

  2. Nakajima H, Park HL, Henkart PA. Synergistic roles of granzymes A and B in mediating target cell death by RBL mast cell tumors also expressing cytolysin/perforin. J.Exp.Med. 1995 181:1037-1046.

  3. Nakajima H, Golstein P, and Henkart PA. The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity. J.Exp.Med. 1995 181:1905-1909.

  4. Sarin A, Nakajima H, Henkart, PA. A protease-dependent TcR-induced death pathway in mature lymphocytes. J.Immunol. 1995 154:5806-5812.

  5. Sarin A, Conan-Cibotti M and Henkart PA. Cytotoxic effect of tumor necrosis factor and lymphotoxin on T lymphoblasts. J.Immunol. 1995 155:3716-3718.

  6. Henkart PA. Apoptosis: O death, where is thy sting? J.Immunol. 1995 154:4905-4908.

About Pierre Henkart

Dr. Henkart received his Ph.D. in Biochemistry and Molecular Biology from Harvard University, and was a post-doctoral fellow at the University of California, San Diego, before coming to the National Cancer Institute. His laboratory originated and developed the granule exocytosis model for lymphocyte-mediated cytotoxicity over the last 15 years. He has received the Public Health Service Superior Service Award, and serves as a Section Editor for the Journal of Immunology. He also serves on the steering committees of the Apoptosis Interest Group and the Immunology Interest Group, and on the Immunology faculty of the Foundation for Advanced Education in the Sciences at the National Institutes of Health.


Last updated: April 8, 1996, by Pierre Henkart
Return to Apoptosis Interest Group Homepage
Return to Immunology Interest Group Homepage
Return to Experimental Immunology Branch Homepage